APA

Kim N., Cho A., Watanabe H., Choi Y., Aziz M., Kassner M., Joung J., Park A. K., Francis J. M., Bae J. S., Ahn S., Kim K., Park J. O., Park W., Ahn M., Park K., Koo J., Yin H. H. & Cho J. (20171218). Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation. : Oncotarget.

Chicago

Kim Nayoung, Cho Ahye, Watanabe Hideo, Choi Yoon-La, Aziz Meraj, Kassner Michelle, Joung Je-Gun, Park Angela Kyung-Joo, Francis Joshua M, Bae Joon Seol, Ahn Soo-Min, Kim Kyoung-Mee, Park Joon Oh, Park Woong-Yang, Ahn Myung-Ju, Park Keunchil, Koo Jaehyung, Yin Hongwei Holly and Cho Jeonghee. 20171218. Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation. : Oncotarget.

Harvard

Kim N., Cho A., Watanabe H., Choi Y., Aziz M., Kassner M., Joung J., Park A. K., Francis J. M., Bae J. S., Ahn S., Kim K., Park J. O., Park W., Ahn M., Park K., Koo J., Yin H. H. and Cho J. (20171218). Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation. : Oncotarget.

MLA

Kim Nayoung, Cho Ahye, Watanabe Hideo, Choi Yoon-La, Aziz Meraj, Kassner Michelle, Joung Je-Gun, Park Angela Kyung-Joo, Francis Joshua M, Bae Joon Seol, Ahn Soo-Min, Kim Kyoung-Mee, Park Joon Oh, Park Woong-Yang, Ahn Myung-Ju, Park Keunchil, Koo Jaehyung, Yin Hongwei Holly and Cho Jeonghee. Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation. : Oncotarget. 20171218.